Ganglioside GD3 enhances invasiveness of gliomas by forming a complex with platelet-derived growth factor receptor α and yes kinase

Journal of Biological Chemistry

Volumn 290, Issue 26, 2015, Pages 16043-16058

  Ohkawa, Yuki ^a   Momota, Hiroyuki ^a   Kato, Akira ^a   Hashimoto, Noboru ^a   Tsuda, Yusuke ^a   Kotani, Norihiro ^b   Honke, Koichi ^c   Suzumura, Akio ^d   Furukawa, Keiko ^a,e   Ohmi, Yuhsuke ^a   Natsume, Atsushi ^a   Wakabayashi, Toshihiko ^a   Furukawa, Koichi ^a,e  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

^e CHUBU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; CELLS; CYTOLOGY; ENZYMES; HISTOLOGY; MAMMALS; MASS SPECTROMETRY; PLATELETS; TISSUE;

CO-PRECIPITATED; CULTURED CELL; ENZYME-MEDIATED; GLIOMA TISSUES; PLATELET-DERIVED GROWTH FACTOR RECEPTORS; PLATELET-DERIVED GROWTH FACTORS; RADICAL SOURCE; TERNARY COMPLEX;

TUMORS;

GANGLIOSIDE GD2; GANGLIOSIDE GD3; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR B; PROTEIN KINASE B; PROTEIN KINASE YES; SMALL INTERFERING RNA; GANGLIOSIDE; GANGLIOSIDE, GD3; PROTEIN BINDING; YES1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GLIOMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INVASION; ANIMAL; BRAIN TUMOR; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM;

ANIMALS; BRAIN NEOPLASMS; GANGLIOSIDES; GLIOMA; HUMANS; MICE; NEOPLASM INVASIVENESS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-YES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA;

EID: 84941309105     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.635755     Document Type: Article

References (58)

1. Daniotti, J. L., Vilcaes, A. A., Torres Demichelis, V., Ruggiero, F. M., and Rodriguez-Walker, M. (2013) Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approaches. Front. Oncol. 3, 306
2. Hakomori, S. (2004) Glycosynapses: microdomains controlling carbohydrate-dependent cell adhesion and signaling. An. Acad. Bras. Cienc. 76, 553-572
3. Ohmi, Y., Tajima, O., Ohkawa, Y., Yamauchi, Y., Sugiura, Y., and Furukawa, K. (2011) Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: elucidation by a series of ganglioside-deficient mutant mice. J. Neurochem. 116, 926-935
4. Vajn, K., Viljetić, B., Degmečić, I. V., Schnaar, R. L., and Heffer, M. (2013) Differential distribution of major brain gangliosides in the adult mouse central nervous system. PLoS ONE 8, e75720
5. Yu, R. K., Nakatani, Y., and Yanagisawa, M. (2009) The role of glycosphingolipid metabolism in the developing brain. J. Lipid Res. 50, S440-S445
6. Yamashiro, S., Okada, M., Haraguchi, M., Furukawa, K., Lloyd, K. O., and Shiku, H. (1995) Expression of α-2, 8-sialyltransferase (GD3 synthase) gene in human cancer cell lines: high level expression in melanomas and up-regulation in activated T lymphocytes. Glycoconj. J. 12, 894-900
7. Okada, M., Furukawa, K., Yamashiro, S., Yamada, Y., Haraguchi, M., Horibe, K., Kato, K., and Tsuji, Y. (1996) High expression of ganglioside α-2, 8-sialyltransferase (GD3 synthase) gene in adult T-cell leukemia cells unrelated to the gene expression of human T-lymphotropic virus type I. Cancer Res. 56, 2844-2848
8. Wagener, R., Röhn, G., Schillinger, G., Schröder, R., Kobbe, B., and Ernestus, R. I. (1999) Ganglioside profiles in human gliomas: quantification by microbore high performance liquid chromatography and correlation to histomorphology and grading. ActaNeurochir. 141, 1339-1345
9. Vukelić, Z., Kalanj-Bognar, S., Froesch, M., Bîndila, L., Radić, B., Allen, M., Peter-Katalinić, J., and Zamfir, A. D. (2007) Human gliosarcoma-associated ganglioside composition is complex and distinctive as evidenced by high-performance mass spectrometric determination and structural characterization. Glycobiology 17, 504-515
10. Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N, Brennan, C., Chin, L., De Pinho, R. A., and Cavenee, W. K. (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 21, 2683-2710
11. Wen, P. Y., and Kesari, S. (2008) Malignant gliomas in adults. N. Engl. J. Med. 359, 492-507
12. Cancer Genome Atlas Research Network. (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068
13. Verhaak, R. G., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., Alexe, G., Lawrence, M., O'Kelly, M., Tamayo, P., Weir, B. A., Gabriel, S., Winckler, W., Gupta, S., Jakkula, L., Feiler, H. S., Hodgson, J. G., James, C. D., Sarkaria, J. N, Brennan, C, Kahn, A., Spellman, P. T., Wilson, R. K., Speed, T. P., Gray, J. W., Meyerson, M., Getz, G., Perou, C. M., Hayes, D. N, and Cancer Genome Atlas Research Network (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98-110
14. Brennan, C, Momota, H, Hambardzumyan, D., Ozawa, T., Tandon, A., Pedraza, A., and Holland E. (2009) Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS ONE 4, e7752
15. Zhu, H., Acquaviva, J., Ramachandran, P., Boskovitz, A., Woolfenden, S., Pfannl, R., Bronson, R. T., Chen, J. W., Weissleder, R., Housman, D. E., and Charest, A. (2009) Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis. Proc. Natl. Acad. Sci. U. S. A. 106, 2712-2716
16. MacDonald, T. J., Brown, K. M., La Fleur, B., Peterson, K., Lawlor, C, Chen, Y., Packer, R. J., Cogen, P., and Stephan, D. A. (2001) Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet. 29, 143-152
17. Demuth, T., and Berens, M. E. (2004) Molecular mechanisms of glioma cell migration and invasion. J. Neurooncol. 70, 217-228
18. Momota, H., Narita, Y., Matsushita, Y., Miyakita, Y., and Shibui, S. (2010) p53 abnormality and tumor invasion in patients with malignant astrocytoma. Brain Tumor Pathol. 27, 95-101
19. Heyer, J., Kwong, L. N, Lowe, S. W., and Chin, L. (2010) Non-germline genetically engineered mouse models for translational cancer research. Nat. Rev. Cancer 10, 470-480
20. Hambardzumyan, D., Amankulor, N. M., Helmy, K. Y., Becher, O. J., and Holland, E. C. (2009) Modeling adult gliomas using RCAS/t-va technology. Transl. Oncol. 2, 89-95
21. Holland, E. C, and Varmus, H. E. (1998) Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice. Proc. Natl. Acad. Sci. U. S. A. 95, 1218-1223
22. Holland, E. C, Celestino, J., Dai, C, Schaefer, L., Sawaya, R. E., and Fuller, G. N. (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet. 25, 55-57
23. Holland, E. C, Hively, W. P., De Pinho, R. A., and Varmus, H. E. (1998) A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev. 12, 3675-3685
24. Suzumura, A., Sawada, M., and Marunouchi, T. (1996) Selective induction of interleukin-6 mouse microglia by granulocyte-macrophage colonystimulating factor. Brain Res. 713, 192-198
25. Suzumura, A., Mezitis, S. G., Gonatas, N. K., and Silberberg, D. H. (1987) MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by γ-interferon. J. Neuroimmunol. 15, 263-278
26. Zhao, J., Furukawa, K., Fukumoto, S., Okada, M., Furugen, R., Miyazaki, H, Takamiya, K., Aizawa, S., Shiku, H., Matsuyama, T., and Furukawa, K. (1999) Attenuation of interleukin 2 signal in the spleen cells of complex ganglioside-lacking mice. J. Biol. Chem. 274, 13744-13747
27. Hashimoto, N, Hamamura, K., Kotani, N, Furukawa, K., Kaneko, K., and Honke, K. (2012) Proteomic analysis of ganglioside-associated membrane molecules: substantial basis for molecular clustering. Proteomics 12, 3154-3163
28. Eddleston, M., and Mucke, L. (1993) Molecular profile of reactive astrocytes: implications for their role in neurologic disease. Neuroscience 54, 15-36
29. Kawai, K., Kuroda, S., Watarai, S., Takahashi, H, and Ikuta, F. (1994) Occurrence of GD3 gangliosides in reactive astrocytes: an immunocytochemical study in the rat bain. Neurosci. Lett. 174, 225-227
30. Kawai, K., Watarai, S., Takahashi, H., Ishizu, H, Fukai, K., Tanabe, Y., Yokota, O., and Kuroda, S. (1999) Demonstration of ganglioside GD3 in human reactive astrocytes. Psychiatry Clin. Neurosci. 53, 79-82
31. Zamanian, J. L., Xu, L., Foo, L. C, Nouri, N, Zhou, L., Giffard, R. G., and Barres, B. A. (2012) Genomic analysis of reactive astrogliosis. J. Neurosci. 32, 6391-6410
32. Furukawa, K., Ohmi, Y., Ohkawa, Y., Tokuda, N, Kondo, Y., Tajima, O., and Furukawa, K. (2011) Regulatory mechanisms of nervous systems with glycosphingolipids. Neurochem. Res. 36, 1578-1586
33. Kotani, N, Gu, J., Isaji, T., Udaka, K., Taniguchi, N, and Honke, K. (2008) Biochemical visualization of cell surface molecular clustering in living cells. Proc. Natl. Acad. Sci. U. S. A. 105, 7405-7409
34. Deakin, N. O., Pignatelli, J., and Turner, C. E. (2012) Diverse roles for the paxillin family of proteins in cancer. Genes Cancer 3, 362-370
35. Furukawa, K., Hamamura, K., Ohkawa, Y., and Ohmi, Y. (2012) Disialyl gangliosides enhance tumor phenotypes with differential modalities. Glycoconj. J. 29, 579-584
36. Furukawa, K., Ohkawa, Y., Yamauchi, Y., Hamamura, K., and Ohmi, Y. (2012) Fine tuning of cell signals by glycosylation. J. Biochem. 151, 573-578
37. Hamamura, K., Furukawa, K., Hayashi, T., Hattori, T., Nakano, J., Nakashima, H, Okuda, T., Mizutani, H, Hattori, H., Ueda, M., Urano, T., and Lloyd, K. O. (2005) Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells. Proc. Natl. Acad. Sci. U. S. A. 102, 11041-11046
38. Ohkawa, Y., Miyazaki, S., Hamamura, K., Kambe, M., Miyata, M., Tajima, O., Ohmi, Y., Yamauchi, Y., and Furukawa, K. (2010) Ganglioside GD3 enhances adhesion signals and augments malignant properties of melanoma cells by recruiting integrins to glycolipid-enriched microdomains. J. Biol. Chem. 285, 27213-27223
39. Furukawa, K., Kambe, M., Miyata, M., Ohkawa, Y., Tajima, O., and Furukawa, K. (2014) Ganglioside GD3 induces convergence and synergism of adhesion and hepatocyte growth factor/Met signals in melanomas. Cancer Sci. 105, 52-63
40. Shih, A. H, and Holland, E. C. (2006) Platelet-derived growth factor (PDGF) and glial tumorigenesis. Cancer Lett. 232, 139-147
41. Dai, C, Celestino, J. C, Okada, Y., Louis, D. N, Fuller, G. N, and Holland, E. C. (2001) PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 15, 1913-1925
42. Kang, N Y., Kim, C. H, Kim, K. S., Ko, J. H, Lee, J. H., Jeong, Y. K., and Lee, Y. C (2007) Expression of the human CMP-NeuAc: GM3 α2, 8-sialyltransferase (GD3 synthase) gene through the NF-κB activation in human melanoma SK-MEL-2 cells. Biochim. Biophys. Acta 1769, 622-630
43. Miyata, M., Ichihara, M., Tajima, O., Sobue, S., Kambe, M., Sugiura, K., and Furukawa, K. (2014) UVB-irradiated keratinocytes induce melanomaassociated ganglioside GD3 synthase gene in melanocytes via secretion of tumor necrosis factor α and interleukin 6. Biochem. Biophys. Res. Commun. 445, 504-510
44. Park, S., Hatanpaa, K. J., Xie, Y., Mickey, B. E., Madden, C. J., Raisanen, J. M., Ramnarain, D. B., Xiao, G., Saha, D., Boothman, D. A., Zhao, D., Bachoo, R. M., Pieper, R. O., and Habib, A. A. (2009) The receptor interacting protein 1 inhibits p53 induction through NF-κB activation and confers a worse prognosis in glioblastoma. Cancer Res. 69, 2809-2816
45. Lee, D. W., Ramakrishnan, D., Valenta, J., Parney, I. F., Bayless, K. J., and Sitcheran, R. (2013) The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma. PLoS ONE 8, e57489
46. Romashkova, J. A., and Makarov, S. S. (1999) NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401, 86-90
47. Thomas, S. M., and Brugge, J. S. (1997) Cellular functions regulated by Src family kinases. Annu. Rev. CellDev. Biol. 13, 513-609
48. Jung, J., Lee, M. K., Jin, Y., Fu, S. B., Rosales, J. L., and Lee, K. Y. (2011) Clues for c-Yes involvement in the cell cycle and cytokinesis. Cell Cycle 10, 1502-1503
49. Sato, A., Sekine, M., Virgona, N, Ota, M., and Yano, T. (2012) Yes is a central mediator of cell growth in malignant mesothelioma cells. Oncol. Rep. 28, 1889-1893
50. Kleber, S., Sancho-Martinez, I., Wiestler, B., Beisel, A., Gieffers, C, Hill, O., Thiemann, M., Mueller, W., Sykora, J., Kuhn, A., Schreglmann, N, Letellier, E., Zuliani, C, Klussmann, S., Teodorczyk, M., Gröne, H. J., Ganten, T. M., Sültmann, H., Tüttenberg, J., Von Deimling, A., Regnier-Vigouroux, A., Herold-Mende, C, and Martin-Villalba, A. (2008) Yes and PI3K bind CD95 to signal invasion of glioblastoma. Cancer Cell 13, 235-248
51. Hamamura, K., Tsuji, M., Hotta, H., Ohkawa, Y., Takahashi, M., Shibuya, H., Nakashima, H., Yamauchi, Y., Hashimoto, N, Hattori, H., Ueda, M., and Furukawa, K. (2011) Functional activation of Src family kinase yes protein is essential for the enhanced malignant properties of human melanoma cells expressing ganglioside GD3. J. Biol. Chem. 286, 18526-18537
52. Schaller, M. D., and Parsons, J. T. (1995) pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk. Mol. Cell Biol. 15, 2635-2645
53. Deakin, N. O., and Turner, C. E. (2011) Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion and metastasis. Mol. Biol. Cell 22, 327-341
54. Heimburg-Molinaro, J., Lum, M., Vijay, G., Jain, M., Almogren, A., and Rittenhouse-Olson, K. (2011) Cancer vaccines and carbohydrate epitopes. Vaccine 29, 8802-8826
55. Yang, R. K., and Sondel, P. M. (2010) Anti-GD2 strategy in the treatment of neuroblastoma. Drugs Future 35, 665
56. Pule, M. A., Savoldo, B., Myers, G. D., Rossig, C., Russell, H. V., Dotti, G., Huls, M. H., Liu, E., Gee, A. P., Mei, Z., Yvon, E., Weiss, H. L., Liu, H., Rooney, C. M., Heslop, H. E., and Brenner, M. K. (2008) Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma. Nat. Med. 14, 1264-1270
57. Louis, C. U., Savoldo, B., Dotti, G., Pule, M., Yvon, E., Myers, G. D., Rossig, C., Russell, H. V., Diouf, O., Liu, E., Liu, H., Wu, M. F., Gee, A. P., Mei, Z., Rooney, C. M., Heslop, H. E., and Brenner, M. K. (2011) Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood 118, 6050-6056
58. Battula, V. L., Shi, Y., Evans, K. W., Wang, R. Y., Spaeth, E. L., Jacamo, R. O., Guerra, R., Sahin, A. A., Marini, F. C., Hortobagyi, G., Mani, S. A., and Andreeff, M. (2012) Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis. J. Clin. Invest. 122, 2066-2078